News from the FDA/CDC
News from the FDA/CDC
Feds take baseline on EHR interoperability
Survey respondents report challenges with integrating external reports, summaries.
FDA/CDC
CDC: 2017 worst year yet for drug overdoses
Deaths tied to synthetic opioids climbed faster than any other drug class.
News from the FDA/CDC
More deliveries now include opioid use disorder
Significant increases were seen from 1999 to 2014 in all states studied.
News from the FDA/CDC
Fentanyl analogs nearly double their overdose death toll
From 2016 to 2017, carfentanil-related deaths were up 98%.
FDA/CDC
Fluoroquinolones can cause fatal hypoglycemia, FDA warns
News from the FDA/CDC
FDA approves Aristada Initio for schizophrenia
Aristada Initio, a long-acting injectable atypical antipsychotic, is the first on the market to have a 2-month dosing option.
FDA/CDC
Cost led to missed care for 4.5% of Americans in 2017
Steady decline in national rate appears to have halted.
News from the FDA/CDC
Youth tobacco use shows ‘promising declines’
E-cigarettes are now the most popular form of tobacco among middle school students and third among high school students.
FDA/CDC
Bipolar and seizure medication linked with serious immune system reaction
Lamotrigine will carry a warning about hemophagocytic lymphohistiocytosis.
News from the FDA/CDC
Suicide on the minds of many Utah teens
Bullying and substance use may be factors in the state’s increasing youth suicide rate.
FDA/CDC
CDC: Marijuana use may spur industries to rethink current policies
A new report from the CDC clears some of the smoke around marijuana use.